Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure.


Journal

Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480

Informations de publication

Date de publication:
2020
Historique:
received: 25 07 2020
accepted: 01 10 2020
entrez: 11 11 2020
pubmed: 12 11 2020
medline: 2 3 2021
Statut: epublish

Résumé

Heart failure (HF) is a common complication of various cardiac diseases, and its incidence constantly increases. This is caused mainly by aging of populations and improvement in the treatment of coronary artery disease. As HF patients age, they tend to develop comorbidities, creating new problems for health-care professionals. Sarcopenia, defined as the loss of muscle mass and function, and cachexia, defined as weight loss due to an underlying illness, are muscle wasting disorders of particular relevance in the heart failure population, but they go mostly unrecognized. The coexistence of chronic HF and metabolic disorders facilitates the development of cachexia. Cachexia, in turn, significantly worsens a patient's prognosis and quality of life. The mechanisms underlying cachexia have not been explained yet and require further research. Understanding its background is crucial in the development of treatment strategies to prevent and treat tissue wasting. There are currently no specific European guidelines or recommended therapy for cachexia treatment in HF ("cardiac cachexia").

Identifiants

pubmed: 33173285
doi: 10.2147/CIA.S273967
pii: 273967
pmc: PMC7646468
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2041-2051

Informations de copyright

© 2020 Krysztofiak et al.

Déclaration de conflit d'intérêts

The authors have declared no conflict of interest.

Références

Circulation. 2005 Sep 20;112(12):1756-62
pubmed: 16157772
J Cachexia Sarcopenia Muscle. 2010 Sep;1(1):35-42
pubmed: 21475692
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):549-556
pubmed: 28244261
J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1196-1199
pubmed: 30697982
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):312-21
pubmed: 27239412
Am J Cardiol. 2008 Jun 2;101(11A):89E-103E
pubmed: 18514634
ESC Heart Fail. 2014 Sep;1(1):4-25
pubmed: 28834669
Biomed Res Int. 2015;2015:382585
pubmed: 26491666
Cardiovasc Res. 2007 Jan 15;73(2):298-309
pubmed: 17034772
J Obes. 2016;2016:9040248
pubmed: 26904277
J Am Geriatr Soc. 2017 Dec;65(12):2673-2678
pubmed: 28960230
Circ Heart Fail. 2010 Mar;3(2):195-201
pubmed: 20103775
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36
pubmed: 27066316
Prz Gastroenterol. 2013;8(6):383-9
pubmed: 24868288
Anim Sci J. 2010 Feb;81(1):11-20
pubmed: 20163667
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):246-60
pubmed: 27386168
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):507-509
pubmed: 27891294
Nutrients. 2016 Jul 22;8(7):
pubmed: 27455314
Int J Obes (Lond). 2014 Aug;38(8):1110-4
pubmed: 24173404
Clin Biochem. 2014 Jan;47(1-2):8-15
pubmed: 24184665
J Cachexia Sarcopenia Muscle. 2018 Feb;9(1):3-19
pubmed: 29151281
Heart. 2014 Sep 15;100(18):1414-20
pubmed: 24957529
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):263-277
pubmed: 30794350
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):3-4
pubmed: 27066313
Nutrition. 2013 Feb;29(2):436-42
pubmed: 23200301
Int J Biochem Cell Biol. 2013 Oct;45(10):2322-32
pubmed: 23769949
J Nutr Health Aging. 2018;22(5):581-588
pubmed: 29717757
Circulation. 1997 Jul 15;96(2):526-34
pubmed: 9244221
Age Ageing. 1995 Nov;24(6):481-4
pubmed: 8588536
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):261-3
pubmed: 25384990
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):299-311
pubmed: 27239407
J Cachexia Sarcopenia Muscle. 2017 Apr;8(2):187-189
pubmed: 28145079
J Am Heart Assoc. 2016 Mar 24;5(3):e002468
pubmed: 27013541
ESC Heart Fail. 2018 Dec;5(6):1099-1107
pubmed: 30548178
Proc Natl Acad Sci U S A. 1990 Nov;87(22):8931-4
pubmed: 2247468
Eur J Sport Sci. 2017 Jul;17(6):710-719
pubmed: 28319679
Am J Med Sci. 2015 Oct;350(4):250-6
pubmed: 26083652
Clin Med Res. 2007 Dec;5(4):238-43
pubmed: 18367709
Int J Cardiol. 2016 Jan 1;202:446-7
pubmed: 26433767
Curr Opin Endocrinol Diabetes Obes. 2011 Jun;18(3):224-30
pubmed: 21494135
Am J Physiol Heart Circ Physiol. 2010 May;298(5):H1565-70
pubmed: 20228261
Am J Cardiovasc Drugs. 2017 Jun;17(3):183-201
pubmed: 28039585
J Am Coll Cardiol. 2010 Oct 5;56(15):1196-204
pubmed: 20883926
Clin Nutr. 2008 Dec;27(6):793-9
pubmed: 18718696
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):151-156
pubmed: 29852198
Curr Heart Fail Rep. 2014 Sep;11(3):266-73
pubmed: 24733407
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
J Am Coll Cardiol. 2008 Aug 5;52(6):428-34
pubmed: 18672162
Heart Fail Rev. 2019 Sep;24(5):617-623
pubmed: 30923991
Circulation. 2001 May 1;103(17):2195-200
pubmed: 11331262
Cardiovasc Res. 2011 May 1;90(2):191-3
pubmed: 21429943
Int Heart J. 2019 Mar 20;60(2):384-391
pubmed: 30799377
J Cardiovasc Med (Hagerstown). 2008 Jun;9(6):576-80
pubmed: 18475125
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):269-71
pubmed: 26675043
Clin Cardiol. 2011 Apr;34(4):211-7
pubmed: 21462215
Lancet. 2003 Mar 29;361(9363):1077-83
pubmed: 12672310
Korean Circ J. 2017 Sep;47(5):663-669
pubmed: 28955383
Curr Probl Cardiol. 2020 Nov;45(11):100417
pubmed: 31036371
Arq Bras Cardiol. 2017 Jan;108(1):74-80
pubmed: 27812676
J Card Fail. 2019 May;25(5):380-400
pubmed: 30877038
Br J Cancer. 2005 Aug 22;93(4):425-34
pubmed: 16052213
ESC Heart Fail. 2015 Sep;2(3):168-170
pubmed: 28834671
Curr Opin Clin Nutr Metab Care. 2019 Jan;22(1):1-3
pubmed: 30431471
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):870-880
pubmed: 29168628
Eur J Heart Fail. 2015 Oct;17(10):1015-21
pubmed: 26198713
Heart Fail Clin. 2009 Oct;5(4):549-60
pubmed: 19631179
Am J Cardiol. 1999 Feb 1;83(3):376-82
pubmed: 10072227
J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):290-8
pubmed: 27239410
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):90-4
pubmed: 27128291
Int J Cardiol. 2017 Jul 1;238:5-11
pubmed: 28427849
JACC Heart Fail. 2013 Feb;1(1):84-90
pubmed: 24614995
Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):446-454
pubmed: 27885423
Int J Cardiol. 2011 Feb 3;146(3):359-63
pubmed: 19703717
J Cardiol. 2020 Jan;75(1):47-52
pubmed: 31326239
ESC Heart Fail. 2018 Dec;5(6):1092-1098
pubmed: 30570226

Auteurs

Helena Krysztofiak (H)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.

Marta Wleklik (M)

Department of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.

Jacek Migaj (J)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.
Poznan University of Medical Sciences Hospital of Lord's Transfiguration, Poznan, Poland.

Magdalena Dudek (M)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.
Poznan University of Medical Sciences Hospital of Lord's Transfiguration, Poznan, Poland.

Izabella Uchmanowicz (I)

Department of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.

Magdalena Lisiak (M)

Department of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.

Grzegorz Kubielas (G)

Department of Clinical Nursing, Wroclaw Medical University, Wroclaw, Poland.

Ewa Straburzyńska-Migaj (E)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.
Poznan University of Medical Sciences Hospital of Lord's Transfiguration, Poznan, Poland.

Maciej Lesiak (M)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.
Poznan University of Medical Sciences Hospital of Lord's Transfiguration, Poznan, Poland.

Marta Kałużna-Oleksy (M)

1st Department of Cardiology, University of Medical Sciences in Poznan, Poznan, Poland.
Poznan University of Medical Sciences Hospital of Lord's Transfiguration, Poznan, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH